Sarepta Therapeutics Announces Plans to Submit Rolling NDA for Eteplirsen following Today’s Pre-NDA Meeting with the FDA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. NVDA
2. SPY
3. VRTX
4. LGND
5. ONON
6. PSKY
7. META
8. ARAI
9. MA
10. ACN

Go back to Sarepta Therapeutics Announces Plans to Submit Rolling NDA for Eteplirsen following Today’s Pre-NDA Meeting with the FDA
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 20.37 +0.23 (1.14%)
Previous Close $20.14    52 Week High $63.73 
Open $20.46    52 Week Low $8.00 
Day High $20.61    P/E N/A 
Day Low $20.19    EPS $-5.69 
Volume 183,861